What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Surgery
Her primary areas of investigation include Multiple sclerosis, Acute disseminated encephalomyelitis, Pathology, Pediatrics and Neuromyelitis optica.
Her Multiple sclerosis research focuses on Clinically isolated syndrome in particular.
Her Acute disseminated encephalomyelitis research is multidisciplinary, relying on both Myelin oligodendrocyte glycoprotein, Encephalomyelitis, Myelitis and Demyelinating Disorder.
Her Pediatrics study which covers Severity of illness that intersects with Case-control study, Physical examination, Varicella zoster virus and Gold standard.
Her work deals with themes such as Central nervous system, Brainstem, Transverse myelitis, Optic neuritis and Optic nerve, which intersect with Neuromyelitis optica.
Her Surgery study combines topics in areas such as McDonald criteria, Carcinoma and Expanded Disability Status Scale.
Her most cited work include:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (7085 citations)
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (1774 citations)
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (1618 citations)
What are the main themes of her work throughout her whole career to date?
Brenda Banwell spends much of her time researching Multiple sclerosis, Pediatrics, Pathology, Internal medicine and Disease.
Her study in Multiple sclerosis is interdisciplinary in nature, drawing from both Physical therapy, Magnetic resonance imaging and Intensive care medicine.
The concepts of her Pediatrics study are interwoven with issues in McDonald criteria, Neurology, Expanded Disability Status Scale and Cohort.
In Pathology, Brenda Banwell works on issues like Neuromyelitis optica, which are connected to Spectrum disorder.
Her Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology, Surgery and Cardiology.
She works mostly in the field of Acute disseminated encephalomyelitis, limiting it down to topics relating to Optic neuritis and, in certain cases, Transverse myelitis and Demyelinating Disorder, as a part of the same area of interest.
She most often published in these fields:
- Multiple sclerosis (66.32%)
- Pediatrics (23.14%)
- Pathology (19.54%)
What were the highlights of her more recent work (between 2017-2021)?
- Multiple sclerosis (66.32%)
- Pediatrics (23.14%)
- Internal medicine (19.54%)
In recent papers she was focusing on the following fields of study:
Brenda Banwell mostly deals with Multiple sclerosis, Pediatrics, Internal medicine, Disease and Magnetic resonance imaging.
Her Multiple sclerosis study deals with Clinical trial intersecting with Intensive care medicine and Neurology.
The various areas that Brenda Banwell examines in her Pediatrics study include Odds ratio and Rate ratio.
Her work carried out in the field of Disease brings together such families of science as Radiology and Spinal cord.
Her Magnetic resonance imaging research is multidisciplinary, incorporating perspectives in Neuroimaging, Medical diagnosis and Brain tissue.
Her biological study spans a wide range of topics, including Demyelinating disease and McDonald criteria.
Between 2017 and 2021, her most popular works were:
- Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. (101 citations)
- Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. (78 citations)
- Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. (77 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Her main research concerns Multiple sclerosis, Internal medicine, Clinical trial, Fingolimod and Disease.
Her Multiple sclerosis research includes themes of Magnetic resonance imaging, Pediatrics and Intensive care medicine.
Her Pediatrics study integrates concerns from other disciplines, such as McDonald criteria and Neurology.
Brenda Banwell has researched Clinical trial in several fields, including Randomized controlled trial and Secondary prevention.
Brenda Banwell interconnects Oncology, Multicenter study, T2 lesions, Interferon and Expanded Disability Status Scale in the investigation of issues within Fingolimod.
Her research integrates issues of Transverse myelitis, Interquartile range and Optic neuritis in her study of Myelin oligodendrocyte glycoprotein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
